NM_006772.3:c.763-122C>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006772.3(SYNGAP1):c.763-122C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000818 in 1,222,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006772.3 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYNGAP1 | NM_006772.3 | c.763-122C>A | intron_variant | Intron 7 of 18 | ENST00000646630.1 | NP_006763.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNGAP1 | ENST00000646630.1 | c.763-122C>A | intron_variant | Intron 7 of 18 | NM_006772.3 | ENSP00000496007.1 | ||||
SYNGAP1 | ENST00000644458.1 | c.763-122C>A | intron_variant | Intron 7 of 18 | ENSP00000495541.1 | |||||
SYNGAP1 | ENST00000449372.7 | c.763-122C>A | intron_variant | Intron 7 of 17 | 5 | ENSP00000416519.4 | ||||
SYNGAP1 | ENST00000418600.7 | c.763-122C>A | intron_variant | Intron 7 of 18 | 5 | ENSP00000403636.3 | ||||
SYNGAP1 | ENST00000645250.1 | c.586-122C>A | intron_variant | Intron 5 of 16 | ENSP00000494861.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 8.18e-7 AC: 1AN: 1222590Hom.: 0 Cov.: 18 AF XY: 0.00000163 AC XY: 1AN XY: 613130
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.